Proteasome inhibitor MG132 induces death receptor 5 through CCAAT/enhancer-binding protein homologous protein
- PMID: 15994939
- DOI: 10.1158/0008-5472.CAN-05-0693
Proteasome inhibitor MG132 induces death receptor 5 through CCAAT/enhancer-binding protein homologous protein
Abstract
Combined treatment with a proteasome inhibitor and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is a promising strategy for cancer therapy. Proteasome inhibitors induce the expression of death receptor 5 (DR5), a receptor for TRAIL, and sensitize cancer cells to TRAIL-induced apoptosis; however, the molecular mechanism of DR5 up-regulation has not been elucidated. In this study, we report that CCAAT/enhancer-binding protein homologous protein (CHOP) is a regulator of DR5 induction by proteasome inhibitor MG132. MG132 induced DR5 expression at a protein and mRNA level in prostate cancer DU145 cells. Furthermore, MG132 increased DR5 promoter activity. Using a series of deletion mutant plasmids containing DR5 promoters of various sizes, we found that MG132 stimulated the promoter activity via the region of -289 to -253. This region contained a CHOP-binding site. Site-directed mutation of the site abrogated the promoter activity enhanced by MG132. An electrophoretic mobility shift assay showed that CHOP directly bound to the MG132-responsive site on the DR5 promoter. Expression of the CHOP protein was increased with MG132 along with DR5 up-regulation. Furthermore, CHOP small interfering RNA attenuated the DR5 up-regulation due to MG132. These results indicate that the proteasome inhibitor MG132 induces DR5 expression through CHOP up-regulation.
Similar articles
-
Tunicamycin enhances tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human prostate cancer cells.Cancer Res. 2005 Jul 15;65(14):6364-70. doi: 10.1158/0008-5472.CAN-05-0312. Cancer Res. 2005. PMID: 16024639
-
Curcumin sensitizes tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis through CHOP-independent DR5 upregulation.Carcinogenesis. 2006 Oct;27(10):2008-17. doi: 10.1093/carcin/bgl026. Epub 2006 Apr 12. Carcinogenesis. 2006. PMID: 16613838
-
Anti-gout agent allopurinol exerts cytotoxicity to human hormone-refractory prostate cancer cells in combination with tumor necrosis factor-related apoptosis-inducing ligand.Mol Cancer Res. 2008 Dec;6(12):1852-60. doi: 10.1158/1541-7786.MCR-08-0012. Mol Cancer Res. 2008. PMID: 19074830
-
Myc tagging along the TRAIL to death receptor 5.Cell Cycle. 2004 Jul;3(7):920-2. Epub 2004 Jul 8. Cell Cycle. 2004. PMID: 15254425 Review.
-
MG132, a proteasome inhibitor, induces apoptosis in tumor cells.Asia Pac J Clin Oncol. 2013 Mar;9(1):6-11. doi: 10.1111/j.1743-7563.2012.01535.x. Epub 2012 May 15. Asia Pac J Clin Oncol. 2013. PMID: 22897979 Review.
Cited by
-
Ixazomib promotes CHOP-dependent DR5 induction and apoptosis in colorectal cancer cells.Cancer Biol Ther. 2019;20(3):284-294. doi: 10.1080/15384047.2018.1529095. Epub 2018 Oct 25. Cancer Biol Ther. 2019. PMID: 30359552 Free PMC article.
-
The integrated stress response and proteotoxicity in cancer therapy.Biochem Biophys Res Commun. 2017 Jan 15;482(3):450-453. doi: 10.1016/j.bbrc.2016.11.047. Epub 2017 Feb 3. Biochem Biophys Res Commun. 2017. PMID: 28212730 Free PMC article. Review.
-
NPI-0052, a novel proteasome inhibitor, induces caspase-8 and ROS-dependent apoptosis alone and in combination with HDAC inhibitors in leukemia cells.Blood. 2007 Jul 1;110(1):267-77. doi: 10.1182/blood-2006-03-013128. Epub 2007 Mar 13. Blood. 2007. PMID: 17356134 Free PMC article.
-
The eIF4E/eIF4G interaction inhibitor 4EGI-1 augments TRAIL-mediated apoptosis through c-FLIP Down-regulation and DR5 induction independent of inhibition of cap-dependent protein translation.Neoplasia. 2010 Apr;12(4):346-56. doi: 10.1593/neo.10144. Neoplasia. 2010. PMID: 20360945 Free PMC article.
-
Modulation of TRAIL resistance in colon carcinoma cells: different contributions of DR4 and DR5.BMC Cancer. 2011 Jan 27;11:39. doi: 10.1186/1471-2407-11-39. BMC Cancer. 2011. PMID: 21272366 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials